Biotech · Private company · Princeton, NJ, US
Sonnet BioTherapeutics Holdings, Inc.
SEC CIK 0001106838
Track this companyFree. Adds Sonnet BioTherapeutics Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- SON-1010Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian CancerPHASE1_PHASE2 · TERMINATED · started Sep 15, 2023ClinicalTrials.gov NCT05756907 · fetched Nov 12, 2026
- Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 20, 2022ClinicalTrials.gov NCT05352750 · fetched Nov 12, 2026
SEC filings12
- 10-K/A · 10-K/ASEC EDGAR · filed Jul 17, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Dec 16, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 3, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 2, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 18, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 29, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 1, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 25, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 18, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 2, 2025 · fetched Nov 12, 2026